Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2236 to 2250 of 8900 results

  1. Cipaglucosidase alfa with miglustat for treating late-onset Pompe disease in people 12 to 17 years [TSID11887]

    Topic prioritisation

  2. Dapsone for treating COVID-19 in people 40 years and over with high-risk comorbidity and people 70 years and over [TSID11892]

    Topic prioritisation

  3. Subcutaneous ocrelizumab for treating primary progressive or relapsing multiple sclerosis [TSID11895]

    Topic prioritisation

  4. Avtozma (tocilizumab biosimilar) for treating moderate to severe rheumatoid arthritis in people aged 18 to 75 [TSID11848]

    Topic prioritisation

  5. Levodopa, carbidopa monohydrate and entacapone intestinal gel for treating the symptoms of advanced Parkinson's disease [ID4005]

    Topic prioritisation

  6. Natalizumab for treating highly active relapsing-remitting multiple sclerosis [ID4020]

    Topic prioritisation

  7. Prolonged-release diazoxide choline for treating Prader-Willi syndrome [ID1389]

    Topic prioritisation

  8. Natural Cycles for monitoring fertility

    Topic prioritisation

  9. Cyanoacrylate glue for hernia mesh fixation

    Topic prioritisation

  10. Arthrosamid for symptomatic treatment of knee osteoarthritis

    Topic prioritisation

  11. Nitisinone for treating alkaptonuria [ID2691]

    Topic prioritisation

  12. Remimazolam for general anaesthesia [ID3796]

    Topic prioritisation

  13. Treprostinil for treating symptomatic chronic thromboembolic pulmonary hypertension [ID3926 ]

    Topic prioritisation

  14. Fingolimod for treating relapsing multiple sclerosis in children and young people [ID1378]

    Topic prioritisation